CytomX Therapeutics Revenue 2014-2021 | CTMX

CytomX Therapeutics revenue from 2014 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
CytomX Therapeutics Annual Revenue
(Millions of US $)
2020 $100
2019 $57
2018 $60
2017 $72
2016 $15
2015 $8
2014 $5
2013 $1
CytomX Therapeutics Quarterly Revenue
(Millions of US $)
2021-09-30 $18
2021-06-30 $16
2021-03-31 $16
2020-12-31 $16
2020-09-30 $18
2020-06-30 $17
2020-03-31 $50
2019-12-31 $8
2019-09-30 $11
2019-06-30 $9
2019-03-31 $29
2018-12-31 $11
2018-09-30 $13
2018-06-30 $21
2018-03-31 $14
2017-12-31 $27
2017-09-30 $24
2017-06-30 $9
2017-03-31 $12
2016-12-31 $6
2016-09-30 $3
2016-06-30 $3
2016-03-31 $2
2015-12-31 $2
2015-09-30 $2
2015-06-30 $2
2015-03-31 $2
2014-12-31
2014-09-30 $2
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.271B $0.100B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.345B 9.06
Bio-Rad Laboratories (BIO.B) United States $18.101B 36.73
QIAGEN (QGEN) Netherlands $11.301B 19.14
Biohaven Pharmaceutical Holding (BHVN) United States $7.598B 0.00
Emergent Biosolutions (EBS) United States $2.503B 9.00
Arcus Biosciences (RCUS) United States $2.274B 0.00
Myovant Sciences (MYOV) United Kingdom $1.296B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.081B 0.00
Zymeworks (ZYME) Canada $0.538B 0.00
SQZ Biotechnologies (SQZ) United States $0.203B 0.00
Ambrx Biopharma (AMAM) United States $0.201B 0.00
Enzo Biochem (ENZ) United States $0.155B 20.00